Abstract: An outdoor tent with a modular base includes a main body and a base, the main body being detachably arranged on the base. The base includes a first module and several splicing modules, said several splicing modules being detachably connected to the periphery of the first module, and the first module can be folded to form a box structure, and said several splicing modules can be independently folded and stored in the box formed by the first module. When the base is in the storage state, the first module is folded to form a box structure in which items can be placed, and the second module, third module, fourth module and fifth module are folded and accommodated in the box formed by the first module, reducing space occupation during transportation, improving utilization rate of user space during transportation, and making it easy to carry and transport.

Abstract: A tent with a charging device and wiring thereof includes a main body that includes a frame and a wall, the frame being connected to the wall. The tent also includes an electrical component, which includes an electrical appliance, a power supply and an electric wire. The electrical appliance and the power supply are electrically connected through the electric wire, and the electrical appliance and the electric wire are detachably or fixedly arranged on the frame and/or the wall. For the tent with a charging device and wiring thereof, electrical appliances and electric wires are reasonably arranged on the frame or the wall of the tent in a fixed or manner, by which layout of electrical appliances and electric wires is more reasonable and regular, and the electrical appliances and electric wires will not occupy activity space in the tent, effectively improving users' experience on tents.

Abstract: The present invention relates to a method for measuring the ion nonextensive parameter of plasma includes the following steps: describe the plasma with nonextensive statistical mechanics, obtain the equation describing the relationship between the geodesic acoustic mode frequency and the ion acoustic speed of plasma; collect the measurement data of the geodesic acoustic mode frequencies and plasma temperature in the device where the plasma is to be measured; the obtained equation describing the relationship between the geodesic acoustic mode frequency and the ion acoustic speed of plasma is used to linearly fit the collected measured data of the geodesic acoustic mode frequency and the plasma temperature in the device where the plasma is to be measured to obtain the slope value; based on the derived equation and the obtained slope values, and combining with the safety factor of the device where the plasma is to be measured, the ion nonextensive parameter is solved numerically.

Abstract: The present invention relates to a method for measuring the ion nonextensive parameter of plasma includes the following steps: describe the plasma with nonextensive statistical mechanics, obtain the equation describing the relationship between the geodesic acoustic mode frequency and the ion acoustic speed of plasma; collect the measurement data of the geodesic acoustic mode frequencies and plasma temperature in the device where the plasma is to be measured; the obtained equation describing the relationship between the geodesic acoustic mode frequency and the ion acoustic speed of plasma is used to linearly fit the collected measured data of the geodesic acoustic mode frequency and the plasma temperature in the device where the plasma is to be measured to obtain the slope value; based on the derived equation and the obtained slope values, and combining with the safety factor of the device where the plasma is to be measured, the ion nonextensive parameter is solved numerically.

Abstract: The present invention relates to the use of one or more biomarkers to evaluate the likelihood that a rapamycin analog would produce an anti-cancer effect in a subject. It is based, at least in part, on the results of experiments employing an integrated next-generation sequencing approach to interrogate spatially separated tumor specimens from the same individuals to decipher intra-tumor and intertumor heterogeneity and determine the oncogenomic basis of exceptional therapeutic benefit to rapalogs in kidney cancer patients. These experiments implicated loss of function mutations in TSC1 and/or TSC2 and/or gain-of-function of mTOR in therapeutic responsiveness to rapamycin analogs.

Abstract: The present invention relates to the use of one or more biomarkers to evaluate the likelihood that a rapamycin analog would produce an anti-cancer effect in a subject. It is based, at least in part, on the results of experiments employing an integrated next-generation sequencing approach to interrogate spatially separated tumor specimens from the same individuals to decipher intra-tumor and intertumor heterogeneity and determine the oncogenomic basis of exceptional therapeutic benefit to rapalogs in kidney cancer patients. These experiments implicated loss of function mutations in TSC1 and/or TSC2 and/or gain-of-function of mTOR in therapeutic responsiveness to rapamycin analogs.